BIRB796, an Inhibitor of p38 Mitogen-Activated Protein Kinase, Inhibits Proliferation and Invasion in Glioblastoma Cells
Author:
Affiliation:
1. Department of Neurosurgery, Renmin Hospital of Wuhan University, Hubei 430060, China
2. Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, PR China
Funder
National Natural Science Foundation of China
Publisher
American Chemical Society (ACS)
Subject
General Chemical Engineering,General Chemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/acsomega.1c00521
Reference31 articles.
1. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
2. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
3. Glioblastoma: pathology, molecular mechanisms and markers
4. A PRDX1-p38α heterodimer amplifies MET-driven invasion ofIDH-wildtype andIDH-mutant gliomas
5. p38 MAPK-dependent Nrf2 induction enhances the resistance of glioma cells against TMZ
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Whey protein and flaxseed gum co-encapsulated fucoxanthin promoted tumor cells apoptosis based on MAPK-PI3K/Akt regulation on Huh-7 cell xenografted nude mice;International Journal of Biological Macromolecules;2024-10
2. Phytoconstituents as modulators of NF-κB signalling: Investigating therapeutic potential for diabetic wound healing;Biomedicine & Pharmacotherapy;2024-08
3. The interplay of p38 MAPK signaling and mitochondrial metabolism, a dynamic target in cancer and pathological contexts;Biochemical Pharmacology;2024-07
4. Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors;Pharmaceuticals;2024-03-01
5. Exploring the Potential of Thymoquinone-Stabilized Selenium Nanoparticles: In HEC1B Endometrial Cancer Cells Revealing Enhanced Anticancer Efficacy;ACS Omega;2023-10-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3